DR REDDYS LABORATORIES LTD — Interim / Quarterly Report 2022

Oct 30, 2021

==> picture [452 x 127] intentionally omitted <==

October 30, 2021

To, The Secretary/Executive Director BSE Limited National Stock Exchange of India Limited New York Stock Exchange, Inc. NSE-IFSC Limited

Dear Sir/Madam,

Sub: Newspaper advertisement regarding financial results for the quarter and half-year ended September 30, 2021

Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended, please find enclosed copies of newspaper advertisement regarding the financial results of the company for the quarter and half-year ended September 30, 2021 as published in Business Standard and Andhra Prabha on October 30, 2021.

This is for your information and records.

With regards,

SANDEEP Digitally signed by SANDEEP PODDAR PODDAR Date: 2021.10.30 22:22:19 +05'30' Sandeep Poddar Company Secretary

Encl: as above

SANDEE Digitally signed by SANDEEP P PODDAR Date: 2021.10.30 PODDAR 22:22:56 +05'30'

Andhra Prabha – October 30, 2021

Notes

• I) The obove 1s on ex1roct of the deto,led format of Quarterly Finonc,ol Results of the Company for the quarter and hall year ended September

• 30, 2021 filed with the Stock Exchange under Regulation 52 of the SEBI (L sling Obligot,,,ns and Disclosure Requirements) Regulations, 20[1] 5. The fu I format ol the quorterly financial results ore available on the websites of BSE Limited and the Company at www.ovonse.com

• 2) for the other line ,terns refer-ed ,n Regulotion 52 (4) of the SEBI (Listing and Other Disclosure Requirements) Regulations, 2015, the pertinent disclosures hove been mode to BSE Limited ondcon be accessed on www.bseind,o.com

• 3 Networth 1s equal to po,d up equity shore cop,tol plus other equ,ty less deferred tax assets less ntong,ble assets less right of use asset and corresponding l,obil,t,es

• 4) Capitol Redernphor> Reserve, Debenture Redemption Reserve, Debt Service Coverage Ratio ond Interest Serv,ce Coverage Ratio ore not oppl1cob e os pcrRegu at on 52 (4) of the SEBI (Listing and Other Disclosure Requirements) Regulations, 2015.

• 5) Previous period/year figures hove been regrouped / reclossif,ed wherever necessary to correspond w,th the current yeor class ficohon/d,sdosure

For Avanse Financial Services Ltd Vijayalakshmi Iyer Cho,rperson (DIN 05242960)

Place· Mumbo, Dote: October 28, 2021

•

Dr.Reddy's.

Extract of unaudited financial results of Dr. Reddy's Laboratories Limited and Its subsidiaries for the quarter and half year ended 30 September 2021 prepared In compliance with Indian Accounting Standards

All amounts in Indian Rupees m,lhons	All amounts in Indian Rupees m,lhons	All amounts in Indian Rupees m,lhons	All amounts in Indian Rupees m,lhons
SI. No.	Particulars	Quarter ended 30.09.2021 (Unaudited) Consolidated Half year ended 30.09.2021 (Unaudited) Quarter-· ended 30.09.2020 (Unaudited)
1 2 3 4 5 6 7 8	Total Revenue from operations Net Prahl tor the period (before Tax, Exceptional and/or Extraordinary ,tems) let Profit tor the penod before tax (after Exceptional and/or Extraordinary items) Net Prof,1 for lhe penod after tax (after Exceptional and'or Extraordinary ,ters) Total Comprehensive Income lor the period Equity Share Capital Reseres (excluding Revaluat,on Reserve) Earnings per share(InRupees) per Rs.5;.share Bas,c 0ijuted	57.869 12,725 12,725 9.958 9,643 832 184.612 60.03 59.88 107.320 18,283 18,283 13,762 12.602 832 184,612 82.99 82.77	49,109 8,729 8.729 7,718 7.812 831 165,843 46.54 46.40
SI. No.	Particulars	Quarter ended 30.09.2021 (Unaudited) Standalone - -~~-~~ Half year ended 30.09.2021 (Unaudited) -- -- Quarter ended 30.09.2020 (Unaudited)
1 Total Revenue from operations 38,234 2 Net Profit for the period (before Tax. Exceptional and-or Extraordinary items) 6,487 3 Net Prahl tor the period before tax (after Exceptional and/or Extraordinary items) 6,487 4 Net Prof ti for the period after tax (after Exceptional and/or Extraordinary ,ters) 4,490 5 Total Comprehensive Income for the period 4,625 6 Equity Share Cap,tal 832 7 Reseres (excluding Revalualton Reserve) 173.843 8 Earnings per share (In Rupees) per Rs. 5/· share Basic 27 07 Diluted 27.00 72,569 11.932 11,932 8,624 8.415 832 173,843 52.01 51.87			33,458 6,197 6,197 4,810 5,073 831 162,037 29 00 28.92

Notes.

==> picture [5 x 75] intentionally omitted <==

1 T he above is an extract of the detailed format of Quarterly Financial Results hied with the Stock Exchanges under Regulation 33 al the SEBI (Listing and Other Disclosure Requirements) Regutat,ons, 2015 The full format of the Quarterly Financial Results are availab e on the Stock Exchanges website: www bseind1a com and www.nsemdia.com and also on the Company's website: www.drreddys.com.

• 2 The unaudited results have been reviewed by the Audrt Committee of the Board at their meeting held on 28 October 2021 and approved by the Board of Directors of the Company at the,r meeting held on 29 October 2021.

By order of the Board For Dr. Raddy's Laboratories Limited

Place Hyderabad Date 29 October 2021

G V Prasad Co-Chairman & Managing Director

Dr. REDDY'S LABORATORIES LIMITED

Regd. Office: 8-2-337, Road No.3, Banjara HIiis, HyderablMf • 500 034, Telangana, India CIN: L85195TG1984PLC004507, Tel: 91 40 4900 2900, Fax: 91 40 4900 2999 emall: shares@drreddys.com, website: www.drreddys.com

Business Standard – October 30, 2021

==> picture [55 x 9] intentionally omitted <==

==> picture [64 x 8] intentionally omitted <==

SANDEE Digitally signed P by SANDEEP PODDAR PODDA Date: 2021.10.30 R 22:23:35 +05'30'